SCHEMBL8483686

SCHEMBL8483686

CCCCc1c(N2CCC(NC(=O)c3ccccc3)CC2)ccc2c1C(C(=O)NCC(F)(F)F)c1ccccc1S2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 1/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.36
▸ CARM1 Q86X55 1/20 0.35
▸ PRMT6 Q96LA8 1/20 0.35
▸ MEN1 O00255 7/20 0.35
▸ KMT2A Q03164 7/20 0.35
▸ MCHR1 Q99705 3/20 0.35
▸ CCR3 P51677 1/20 0.35
▸ ADRA1D P25100 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ ADRA1B P35368 1/20 0.35
▸ SLC6A12 P48065 1/20 0.34
▸ TMEM97 Q5BJF2 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ POLB P06746 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ CKS1B P61024 1/20 0.34
▸ SKP1 P63208 1/20 0.34
▸ SKP2 Q13309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8653115 0.89 CCR3 (0.43) CNR1NPSR1MEN1KMT2ACCR3
SCHEMBL8485539 0.87 NPSR1 (0.38) NPSR1CARM1PRMT6MEN1KMT2A
SCHEMBL8484458 0.85 NPSR1 (0.37) NPSR1CARM1PRMT6MEN1KMT2A
SCHEMBL8665881 0.83 DRD2 (0.37) NPSR1CARM1PRMT6KMT2AMCHR1
SCHEMBL8666097 0.81 DRD2 (0.36) NPSR1CARM1PRMT6KMT2AMCHR1
SCHEMBL8501237 0.79 MTTP (0.36) NPSR1MEN1KMT2APOLBLMNA
SCHEMBL8662751 0.79 KMT2A (0.35) MEN1KMT2APOLBSMN1; SMN2MAPT
SCHEMBL8480060 0.78 CCR3 (0.40) NPSR1MEN1KMT2AMCHR1CCR3
SCHEMBL8501050 0.77 MTTP (0.36) MEN1KMT2APOLBALDH1A1
SCHEMBL8483684 0.77 NPSR1 (0.41) NPSR1CARM1PRMT6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883099-A TREATMENT OF ATHERSCLEROSIS, PANCREATITIS OBESITY OR HYPERGLYCEMIA BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-16 — — US disclosed
US-5739135-A PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-14 — — US disclosed
US-5712279-A Inhibitors of microsomal triglyceride transfer protein and method BRISTOL-MYERS SQUIBB COMPANY (US) 1998-01-27 — — US disclosed
Send feedback